Drug and Therapeutics Bulletin 2004;42:1-5; doi:10.1136/dtb.2004.4211
Copyright © 2004 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Medical aspects of drug use in the gym

Use of performance-enhancing drugs by athletes and bodybuilders appears to be common in the UK.1–3 Although there are no comprehensive national figures, there is evidence that such drugs are also widely used in sections of the general and gym-using populations, in the expectation of physical and cosmetic benefits.1,4 Use of performance-enhancing drugs often takes place with little knowledge or acceptance of potential harmful effects, and clinicians in many settings may see patients who are experiencing problems related to such (usually covert) use. Here we consider medical aspects of performance-enhancing drugs.




This article has been cited by other articles:


Home page
 PsychosomaticsHome page
F. J. Huyse, D. J. Touw, R. S. van Schijndel, J. J. de Lange, and J. P.J. Slaets
Psychotropic Drugs and the Perioperative Period: A Proposal for a Guideline in Elective Surgery
Psychosomatics, February 1, 2006; 47(1): 8 - 22.
[Abstract] [Full Text] [PDF]


About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 2004 BMJ Publishing Group Ltd.